vendredi 30 septembre 2016

Onco Actu du 30 septembre 2016

1. Biologie

Flicking the switch on cancer’s immaturity [Cancer Research UK]

Biologists plan scoring system for antibodies [Nature]

2.6 Etiologie - Environnement

Europe's food safety watchdog says to release studies on weed-killer glyphosate [Reuters]

3. Prévention

Men with a high genetic chance of bowel cancer could have lower risk with healthy lifestyle [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

How this ICR PhD student is helping bring personalised medicine to children with cancer [The Institute of Cancer Research]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

US FDA approves TAGRISSO® (osimertinib) blood-based T790M companion diagnostic test [AstraZeneca]

5. Traitements

Ovarian removal to prevent ovarian cancer should not be an option for most premenopausal women, Mayo research finds [Mayo Clinic]

5.12.1 Immunothérapies - partenariats

Boehringer Ingelheim and SARAH CANNON Research Institute launch strategic collaboration to develop novel immune-oncology therapies [Boehringer Ingelheim]

5.12.2 Immunothérapies - CAR-T

Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? [Xconomy]

UCSF scientist rolls out a new blueprint for programming T cells, the 2.0 way [EndPoints]

Cell Design Labs, Little Partner Of Kite Pharma, Pushes T-Cell Engineering Frontier [Forbes]

5.2.1 Pharma - Partenariats

Genentech, South Korean pharma in up to $910M+ RAF inhibitor deal [FierceBiotech]

Genentech snares a PhI RAF inhibitor from Hanmi in $910M deal [EndPoints]

5.3 Traitements - FDA, EMA,...

Are Golden Tickets That Speed Drugs Through FDA Worthwhile? [NPR]

New judicial decisions at odds with EMA’s efforts to allow access to documents on medicines [EMA]

European regulators appeal rulings that prevent release of drug data [STAT]

5.4 Traitements - Economie

The Cancer Drugs Fund is producing dangerous, bad data: randomise everyone, everywhere! [Bad Science]

5.6 ESMO

Bayer to Showcase Latest Oncology Research at ESMO 2016 Congress [Bayer]

ESMO 2016 Press Release: Ki67 May Help Avoid Sentinel Lymph Node Biopsy in Some Patients [ESMO]

Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress [PR Newswire]

5.9.1 ASTRO

Cardiac risk a factor when considering hormonal therapy for prostate cancer [Yale]

6. Lutte contre les cancers

When a Nobel Prize brings a shower of hype: the roller coaster ride of RNAi [STAT]

6.10.1 Politiques (USA)

Senate effort to increase access to experimental drugs is blocked [STAT]

6.11 Patients

Doctors: Breaking Bad News to Patients [NY Times]

6.7.3 DMP

Doctors: E-health records raise costs, don’t help patient outcomes [Computer World]

By The Numbers: Our Progress In Digitizing Health Care [Health Affairs Blog]

6.9 Controverses

How Trump was named ‘Grand Benefactor’ for a Dana-Farber gala without donating a penny [STAT]